Rigel Pharmaceuticals (RIGL) Operating Margin (2010 - 2026)

Rigel Pharmaceuticals' Operating Margin history runs 16 years deep, the most recent figure standing at 20.21% for Q1 2026.

• In Q1 2026, Operating Margin fell 374.0% year-over-year to 20.21%; the TTM figure through Mar 2026 stood at 41.56% (up 1993.0% YoY), while the FY2025 annual figure was 42.63%, up 2914.0% from the prior year.
• Operating Margin was 20.21% for Q1 2026 at Rigel Pharmaceuticals, down from 33.19% in the prior quarter.
• In the past five years, Operating Margin ranged from a high of 60.09% in Q2 2025 to a low of 156.92% in Q1 2022.
• Historically, Operating Margin has averaged 8.64% across 5 years, with a median of 4.05% in 2022.
• Biggest YoY gain for Operating Margin was 10900 bps in 2022; the steepest drop was 20846 bps in 2022.
• A 5-year view of Operating Margin shows it stood at 4.05% in 2022, then surged by 35 bps to 5.49% in 2023, then surged by 426 bps to 28.92% in 2024, then advanced by 15 bps to 33.19% in 2025, then tumbled by 39 bps to 20.21% in 2026.
• The last three Operating Margin figures came in at 20.21% (Q1 2026), 33.19% (Q4 2025), and 40.91% (Q3 2025), per Business Quant data.